Pictet Asset Management
CRL icon

Pictet Asset Management’s Charles River Laboratories CRL Stock Holding History

Pictet Asset Management’s Portfolio CRL Stock Details CRL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.35M Sell
10,363
-287
-3% -$51.1K ﹤0.01% 884
2026
Q1 		$1.84M Buy
10,650
+744
+8% +$138K ﹤0.01% 922
2025
Q4 		$1.98M Buy
9,906
+1,692
+21% +$307K ﹤0.01% 906
2025
Q3 		$1.29M Sell
8,214
-2,297
-22% -$365K ﹤0.01% 976
2025
Q2 		$1.59M Sell
10,511
-1,045
-9% -$139K ﹤0.01% 918
2025
Q1 		$1.74M Sell
11,556
-10,825
-48% -$1.81M ﹤0.01% 914
2024
Q4 		$4.13M Sell
22,381
-38
-0.2% -$7.32K ﹤0.01% 839
2024
Q3 		$4.42M Buy
22,419
+22
+0.1% +$4.57K ﹤0.01% 815
2024
Q2 		$4.63M Sell
22,397
-306
-1% -$69.3K 0.01% 796
2024
Q1 		$6.15M Sell
22,703
-472
-2% -$113K 0.01% 747
2023
Q4 		$5.48M Sell
23,175
-189
-0.8% -$37.2K 0.01% 773
2023
Q3 		$4.58M Buy
+23,364
New +$4.8M 0.01% 788

Other funds holding CRL

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Harris Associates
Harris Associates Chicago, Illinois $75.4B AUM 14.46% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Allspring Global Investments
Allspring Global Investments Charlotte, North Carolina $65.2B AUM 39.42% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
AI
Ariel Investments Chicago, Illinois $10B AUM 42.59% 1-Year Est. Return

Pictet Asset Management's CRL Position: Q2 2026 in Review

Pictet Asset Management reduced its Charles River Laboratories (CRL) stake by 2.7% in Q2 2026, selling an estimated $51.1K and leaving 10,363 shares worth $2.35M. The position accounts for ﹤0.01% of the portfolio, ranked #884.

Pictet Asset Management first reported a position in CRL in Q3 2023 and has held it in 12 quarters since. The position peaked at $6.15M in Q1 2024. 570 funds tracked by Wall St. Rank hold CRL as of Q2 2026.

  • Pictet Asset Management held 10,363 shares of Charles River Laboratories worth $2.35M as of Q2 2026.
  • Pictet Asset Management sold 287 Charles River Laboratories shares in Q2 2026, an estimated $51.1K.
  • Charles River Laboratories made up ﹤0.01% of Pictet Asset Management's portfolio in Q2 2026, its #884 holding.
  • Pictet Asset Management first reported a position in Charles River Laboratories in Q3 2023 and has held it in 12 quarters since.
  • Pictet Asset Management's Charles River Laboratories position peaked at $6.15M in Q1 2024.
  • 570 funds tracked by Wall St. Rank held Charles River Laboratories as of Q2 2026.

Based on Pictet Asset Management's 13F filing for Q2 2026, filed 30 Jul 2026.